Which begs the question, as Rachel so succintly said, why not? Why has a
useful OTC drug in UK and Netherlands never made it into US pharm? Lack of
profit???
Will "orphan" drug status, now give researchers the ability to study it's
safety and efficacy so we can eventually use it in the US?
Seems unreal. Pat in SNJ
***********************************************
Archives: http://community.lsoft.com/archives/LACTNET.html
To reach list owners: [log in to unmask]
Mail all list management commands to: [log in to unmask]
COMMANDS:
1. To temporarily stop your subscription write in the body of an email: set lactnet nomail
2. To start it again: set lactnet mail
3. To unsubscribe: unsubscribe lactnet
4. To get a comprehensive list of rules and directions: get lactnet welcome